Drug Name:
AMEAL BP OTC
Generic Name and Formulations:
AmealPeptide (valyl-prolyl-proline, isoleucyl-prolyl-proline) 5mg per serving; caps or chewable tabs (citrus flavor); contains sodium 15mg/2 caps, 10mg/3 tabs; chew tabs contain phenylalanine.
Company:
Calpis USA, Inc.
Therapeutic Use:
Indications for AMEAL BP:
Dietary supplement to help maintain blood pressure in patients already within normal range.
Adult:
2 capsules or 3 chew tabs daily.
Children:
Not applicable.
How Supplied:
Caps—60
Chew tabs—90
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Demoralization Common in Patients With Parkinson Disease
- American Academy of Neurology Annual Meeting 2018: What to Expect
- Connection Between Essential Tremor, Depression Remains Unclear
- Palliative Care in Movement Disorders: Recommendations for Improvement
- The Symbiosis of Headache and Sleep
- Assessing and Treating Cognitive, Mood Impairments in Patients With Stroke
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Headache in Older Adults: Unique Causes and Treatments
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Switching to Oral Fingolimod From Injectable Treatment Linked to Fewer MS Relapses
- Blood Pressure-Dementia Link May Be Affected by Population Characteristics
- Serotonin Reuptake Inhibitors May Improve OSA in Depression With and Without Epilepsy
- AAN: High Fish Intake Linked to Reduced Risk of Multiple Sclerosis